AI assistant
Sending…
CERUS CORP — Director's Dealing 2011
May 20, 2011
33349_dirs_2011-05-19_d2ddfa99-431b-4776-b17a-90f218ef97b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CERUS CORP (CERS)
CIK: 0001020214
Period of Report: 2011-05-17
Reporting Person: CORASH LAURENCE M (Director, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-17 | Common Stock | P | 5000 | $2.9540 | Acquired | 506700 | Direct |
| 2011-05-18 | Common Stock | P | 3500 | $2.9171 | Acquired | 510200 | Direct |
| 2011-05-19 | Common Stock | P | 12000 | $2.9548 | Acquired | 522200 | Direct |
Footnotes
F1: The price range is between $2.95 and $2.96 per share.
F2: The price range is between $2.91 and $2.92 per share.
F3: The price range is between $2.92 and $2.97 per share.
More from CERUS CORP
Interim / Quarterly Report
2026
Apr 30
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 24
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Nov 26